Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 06/28/2025 at 00:05, 5 months 7 days ago

Collaboration entre Onco-Innovations et AstraZeneca au sein du consortium IA-Oncologie

Recherche Sur Le Cancer Oncologie IA Consortium PROmAI Partenariat Avec AstraZeneca IA Causale
PRESS RELEASE

published on 06/28/2025 at 00:00, 5 months 7 days ago

Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
Onco-Innovations' Inka Health receives Expression of Interest from AstraZeneca to join PROmAI Consortium, advancing AI solutions in oncology. AstraZeneca's involvement reinforces the Consortium's mission of enhancing predictive cancer research

Oncology AstraZeneca Onco-Innovations Inka Health PROmAI Consortium
BRIEF

published on 06/26/2025 at 00:05, 5 months 9 days ago

Onco-Innovations annonce une conférence téléphonique spéciale pour les investisseurs

Conférence Des Investisseurs Recherche Sur Le Cancer Onco-Innovations Thomas O'Shaughnessy Juillet 2025
BRIEF

published on 06/26/2025 at 00:05, 5 months 9 days ago

Onco-Innovations Announces Special Investors' Conference Call

Cancer Research Onco-Innovations Thomas O'Shaughnessy July 2025 Investors' Conference
PRESS RELEASE

published on 06/26/2025 at 00:00, 5 months 9 days ago

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
Onco-Innovations Limited announces special investor conference call with CEO Thomas O'Shaughnessy on July 2, 2025. Join at link.meetingpanel.com, or via toll-free number

Patented Technology Cancer Research Investor Conference Call Onco-Innovations Limited Thomas O'Shaughnessy
BRIEF

published on 06/21/2025 at 00:05, 5 months 14 days ago

Onco-Innovations Subsidiary Explores Real-World Relevance of Lung Cancer Trials

Patient Outcomes Clinical Trials Real-world Data Lung Cancer AI Analytics
BRIEF

published on 06/21/2025 at 00:05, 5 months 14 days ago

La filiale d'Onco-Innovations explore la pertinence des essais cliniques sur le cancer du poumon dans le monde réel

Essais Cliniques Données Du Monde Réel Cancer Du Poumon Résultats Pour Les Patients Analyse De L'IA
PRESS RELEASE

published on 06/21/2025 at 00:00, 5 months 14 days ago

Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
Onco-Innovations subsidiary Inka Health authors significant study on global transportability of clinical trial outcomes to real-world lung cancer populations, published in medRxiv

Clinical Trials Lung Cancer Onco-Innovations Inka Health Real-world Outcomes
BRIEF

published on 06/14/2025 at 00:05, 5 months 21 days ago

Onco-Innovations collabore avec l'Université de l'Alberta sur la recherche sur le cancer

Glioblastome Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Université De L'Alberta
BRIEF

published on 06/14/2025 at 00:05, 5 months 21 days ago

Onco-Innovations Collaborates with University of Alberta on Cancer Research

Cancer Research Glioblastoma Onco-Innovations PNKP Inhibitor University Of Alberta

Accesswire

Published on 12/05/2025 at 20:25, 44 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 54 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 19 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 49 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 24 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 2 hours 11 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 43 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 54 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 3 hours 17 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 3 hours 23 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 11 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE